Advanced Filters
noise

Cervical Cancer Clinical Trials

A listing of Cervical Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 387 clinical trials
C Clinical Trial Referral Office

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

This phase I trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients with solid tumor cancers that have spread to other places in the body (advanced). The experimental vaccine is designed target certain proteins (neoantigens) on individuals' tumor …

18 years of age All Phase 1/2
S Sara Mitchum

SLV-154 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when administered to subjects with metastatic solid tumors.

18 years of age All Phase 1
J Jannet Beukema

Standard Follow-up Program Cervix Cancer (SFP CERVIX)

Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.

years of age Female Phase N/A

Role Of Colposcopy In Evaluation Of Suspicious Cervix

do colposcopy and cervical punch biopsy then compare between findings

18 - 60 years of age Female Phase N/A
V VALENTINA LANCELLOTTA

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

18 years of age Female Phase N/A
Y Yong Li

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Cervical cancer CC is the most common malignant tumor in the female reproductive system, seriously endangering women's health and life, and is one of the leading causes of death for women worldwide.Globally, HPV causes about 85% of cervical cancers and about 60% of oropharyngeal cancers, causing more than 500,000 cancers …

18 - 75 years of age Female Phase N/A

Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims: Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population. Implementation and Assessment: Deploy …

25 - 50 years of age Female Phase N/A

Cervical Cancer Screening With NGS-HPV Technology Based on Menstrual Blood

Our study is conducted to recruit cervical cancer screening patients to evaluate the application value of using high-throughput sequencing technology to detect HPV in menstrual blood for cervical cancer screening.

20 - 55 years of age Female Phase N/A
M Mette tranberg Nielsen, phd

Screening Triage and Risk Stratification

To investigate the performance of cytology, extended genotyping, p16/Ki67 dual stain cytology, DNA methylation and viral load as triage markers in post-menopausal HPV-screen-positive women aged 50-64 years in the organized screening program to predict the risk of developing CIN2+. (work package 1) To investigate the performance of cytology, extended genotyping, …

23 - 64 years of age Female Phase N/A
H Hui Wang, PhD

A Cohort Study of Uterine Malignancies

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic …

20 - 75 years of age Female Phase N/A

Simplify language using AI